Log In
Print
BCIQ
Print
Print this Print this
 

Adasuve (Staccato loxapine) (formerly AZ-004)

  Manage Alerts
Collapse Summary General Information
Company Alexza Pharmaceuticals Inc.
DescriptionLoxapine delivered by Staccato system inhaler
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT2) receptor
Mechanism of ActionDopamine D2 receptor antagonist; Serotonin (5-HT2) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$411.0M

$90.0M

$293.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today